EXHIBIT 99.1
| | | | |
CONTACT: | | Tim Mammen | | David Calusdian |
| | Chief Financial Officer | | Executive Vice President |
| | IPG Photonics Corporation | | Sharon Merrill Associates, Inc. |
| | (508) 373-1100 | | (617) 542-5300 |
IPG PHOTONICS REPORTS 80 PERCENT INCREASE IN NET INCOME
ON 32 PERCENT REVENUE GROWTH FOR THIRD-QUARTER 2007
Fiber Laser Technology Leader Reports Record Results on
Strength of High-Power Laser Sales for Materials Processing
OXFORD, Mass. — November 6, 2007— IPG Photonics Corporation (Nasdaq: IPGP), the leading global manufacturer of high-power lasers and amplifiers for diverse applications in numerous markets, today reported that revenues for the third quarter of 2007 increased by 32.3% to $47.9 million, up from $36.2 million for the third quarter of 2006. For the first nine months of 2007, revenues increased 32.1% to $133.6 million from $101.1 million in the first nine months of 2006. Revenues continue to be driven by strong sales of the Company’s fiber lasers used for materials processing applications, which increased by 36.7% over the third quarter of 2006 to $34.5 million.
Operating income increased 24.0% to $12.8 million for the third quarter of 2007, up from $10.3 million for the same period in 2006. Net income for the third quarter of 2007 increased 80.3% to $8.6 million from $4.7 million in the third quarter of 2006, and earnings per diluted share increased 58.3% to $0.19 from $0.12. Operating expenses for the third quarter of 2007 were $8.9 million, or 18.6% of revenue, compared with $7.0 million, or 19.3% of revenue, in the third quarter of 2006.
For the first nine months of 2007, operating income increased 33.9% to $34.0 million from $25.4 million for the same period in 2006. Net income for the nine-month period increased 71.1% to $21.6 million from $12.6 million, and earnings per diluted share increased 51.6% to $0.47 from $0.31.
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | | | | | | Nine Months Ended | | | | |
| | September 30, | | | | | | | September 30, | | | | |
(In millions, except per share data) | | 2007 | | | 2006 | | | % Change | | | 2007 | | | 2006 | | | % Change | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Revenue | | $ | 47.9 | | | $ | 36.2 | | | | 32.3 | % | | $ | 133.6 | | | $ | 101.1 | | | | 32.1 | % |
Gross Margin | | | 45.3 | % | | | 47.9 | % | | | | | | | 45.9 | % | | | 42.7 | % | | | | |
Operating Income | | $ | 12.8 | | | $ | 10.3 | | | | 24.0 | % | | $ | 34.0 | | | $ | 25.4 | | | | 33.9 | % |
Operating Margin | | | 26.7 | % | | | 28.6 | % | | | | | | | 25.4 | % | | | 25.1 | % | | | | |
Net income | | $ | 8.6 | | | $ | 4.7 | | | | 80.3 | % | | $ | 21.6 | | | $ | 12.6 | | | | 71.1 | % |
Earnings per diluted share | | $ | 0.19 | | | $ | 0.12 | | | | 58.3 | % | | $ | 0.47 | | | $ | 0.31 | | | | 51.6 | % |
IPGP Q3 Results/2
There were no adjustments to net income and earnings per share in the third quarter of 2007. For the third quarter of 2006, adjusted net income was $6.9 million and adjusted earnings per diluted share were $0.17. Adjusted net income and adjusted earnings per share for the third quarter of 2006 are non-GAAP measures. Adjusted net income for the third quarter of 2006 excluded a $2.1 million charge related to the change in the fair value of the Company’s previously outstanding series B warrants, and adjusted earnings per diluted share excluded additional amounts of $0.5 million in accretion related to preferred stock and $0.6 million related to income attributable to preferred stock. Please refer to the exhibit to this press release for a reconciliation of adjusted net income and adjusted earnings per share to net income and earnings per share, respectively, for 2006.
Cash and cash equivalents were $44.8 million on September 30, 2007, compared to $75.7 million on December 31, 2006, primarily as a result of capital expenditures of $26.5 million and the repayment of $18.2 million of term debt, partially offset by net proceeds from our credit lines of $12.7 million.
Comments on the Third Quarter
“The successful execution of our growth strategy resulted in another quarter of record financial results,” said Dr. Valentin Gapontsev, IPG Photonics’ Chief Executive Officer. “Sales of our lasers for materials processing applications drove our revenue growth in the quarter. We are enthusiastic about our opportunities to sell high-power lasers into this market for the long term. We also are generating increasing demand for our fiber laser technology from advanced applications such as test and measurement, instrumentation, sensing, scientific R&D and defense. During this quarter we also saw the beginnings of a rebound in telecommunications sales on the strength of orders from Russia.”
Business Outlook
“Our success thus far in 2007 positions us well for another quarter of solid financial results and further growth in 2008,” said Dr. Gapontsev. “Operationally, the build-out of our manufacturing infrastructure strengthens our status as the only integrated manufacturer of fiber lasers and gives us a significant competitive advantage in the market. Our expanding worldwide presence, including our new office in China, provides us with significant new opportunities. And the strength of our advanced fiber laser technology continues to displace traditional lasers and other non-laser technologies in a wide range of applications.”
For the fourth quarter of 2007, IPG Photonics expects revenues in the range of $51 million to $54 million. The Company anticipates earnings per diluted share in the range of $0.17 to $0.20 based on 45,731,000 common shares, which includes 43,362,000 basic common shares outstanding and 2,369,000 potentially dilutive options at September 30, 2007.
Conference Call Reminder
The Company will hold a conference call to review its financial results and business highlights today, November 6, at 10:00 a.m. ET. The conference call will be webcast live over the Internet and can be accessed on the Investors section of the Company’s website at www.ipgphotonics.com. The conference call can also be accessed by dialing (913) 312-1454 or (888) 244-2460. Interested parties that are unable to listen to the live call may access an archived version of the webcast on IPG’s website.
IPGP Q3 Results/3
Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this press release contains non-GAAP financial measures of adjusted net income and adjusted earnings per share for 2006, in each case excluding the impact of the fair value adjustment to the series B warrants and preferred stock accretion. The Company believes that the inclusion of these non-GAAP financial measures in this press release helps investors to gain a meaningful understanding of growth in the Company’s core operating results and future prospects, and can also help investors who wish to make comparisons between IPG Photonics and other companies. IPG Photonics management uses these non-GAAP measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of the Company’s competitors. These measures also are used by management in its financial and operating decision-making.
The non-GAAP financial measures included in this press release are not meant to be considered superior to or a substitute for results of operations prepared in accordance with GAAP. In addition, the non-GAAP financial measures included in this press release may be different from, and therefore may not be comparable to, similar measures used by other companies. Although non-GAAP financial measures used in this release exclude the accounting treatment of the fair value adjustment to the series B warrants and preferred stock accretion, these non-GAAP measures should not be relied upon independently, as they do not reflect the impact that these items have on the Company’s operating results. Reconciliations of the non-GAAP financial measures used in this press release to the most directly comparable GAAP financial measures are set forth in the exhibit to this press release.
About IPG Photonics Corporation
IPG Photonics is the leading global manufacturer of high-performance fiber lasers and amplifiers for diverse applications in numerous markets, such as materials processing, communications, medical, and scientific and research. Founded in 1990, IPG Photonics pioneered the development and commercialization of optical fiber-based lasers, a new generation of optical sources that combine the advantages of semiconductor diodes with the high amplification and precise beam qualities of specialty optical fibers. Fiber lasers deliver superior performance, reliability and usability at a lower total cost of ownership compared with conventional lasers, allowing end-users to increase productivity and lower operating costs. IPG has its headquarters in Oxford, Massachusetts, and has additional plants and offices throughout the world. For more information, please visit www.ipgphotonics.com.
Safe Harbor Statement
Information and statements provided by the Company and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including, but not limited to, those relating to increasing demand for the Company’s products, growth rates, displacing existing laser technologies, the demand for telecommunications applications, achieving strong performance in the fourth quarter of 2007, and the Company’s revenue and EPS guidance for the fourth quarter of 2007. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the Company’s ability to penetrate new applications for fiber lasers and increase market share, the rate of acceptance and penetration of IPG’s products, effective
IPGP Q3 Results/4
management of growth, level of fixed costs from its vertical integration, intellectual property infringement claims and litigation, interruption in supply of key components, contract cancellations, manufacturing risks, competitive factors including declining average selling prices, building and expanding field service and support operations, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services and other risks identified in the Company’s SEC filings. Readers are encouraged to refer to the risk factors described in the Company’s Annual Report on Form 10-K (filed with the SEC on March 27, 2007) and its periodic reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to rely on the forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update the forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
IPGP-G
IPGP Q3 Results/5
IPG PHOTONICS CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
| | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
| | 2007 | | | 2006 | | | 2007 | | | 2006 | |
| | (in thousands, except per share data) | |
NET SALES | | $ | 47,905 | | | $ | 36,201 | | | $ | 133,610 | | | $ | 101,128 | |
COST OF SALES | | | 26,200 | | | | 18,864 | | | | 72,255 | | | | 57,983 | |
| | | | | | | | | | | | |
GROSS PROFIT | | | 21,705 | | | | 17,337 | | | | 61,355 | | | | 43,145 | |
| | | | | | | | | | | | |
OPERATING EXPENSES: | | | | | | | | | | | | | | | | |
Sales and marketing | | | 2,488 | | | | 1,768 | | | | 7,233 | | | | 4,111 | |
Research and development | | | 2,354 | | | | 1,692 | | | | 6,871 | | | | 4,314 | |
General and administrative | | | 4,049 | | | | 3,539 | | | | 13,279 | | | | 9,352 | |
| | | | | | | | | | | | |
Total operating expenses | | | 8,891 | | | | 6,999 | | | | 27,383 | | | | 17,777 | |
| | | | | | | | | | | | |
OPERATING INCOME | | | 12,814 | | | | 10,338 | | | | 33,972 | | | | 25,368 | |
| | | | | | | | | | | | |
OTHER INCOME (EXPENSE), Net: | | | | | | | | | | | | | | | | |
Interest income (expense), net | | | 198 | | | | (342 | ) | | | 711 | | | | (1,051 | ) |
Fair value adjustment to Series B Warrants | | | — | | | | (2,137 | ) | | | — | | | | (4,356 | ) |
Other income, net | | | 309 | | | | 131 | | | | 345 | | | | 143 | |
| | | | | | | | | | | | |
Total other income (expense) | | | 507 | | | | (2,348 | ) | | | 1,056 | | | | (5,264 | ) |
| | | | | | | | | | | | |
INCOME BEFORE PROVISION FOR INCOME TAXES AND MINORITY INTERESTS IN CONSOLIDATED SUBSIDIARIES | | | 13,321 | | | | 7,990 | | | | 35,028 | | | | 20,104 | |
PROVISION FOR INCOME TAXES | | | (3,505 | ) | | | (2,731 | ) | | | (11,623 | ) | | | (6,597 | ) |
MINORITY INTERESTS IN CONSOLIDATED SUBSIDIARIES | | | (1,259 | ) | | | (512 | ) | | | (1,847 | ) | | | (910 | ) |
| | | | | | | | | | | | |
NET INCOME | | | 8,557 | | | | 4,747 | | | | 21,558 | | | | 12,597 | |
| | | | | | | | | | | | |
NET INCOME PER SHARE: | | | | | | | | | | | | | | | | |
Basic | | $ | 0.20 | | | $ | 0.13 | | | $ | 0.50 | | | $ | 0.34 | |
Diluted | | $ | 0.19 | | | $ | 0.12 | | | $ | 0.47 | | | $ | 0.31 | |
WEIGHTED AVERAGE SHARES | | | | | | | | | | | | | | | | |
Basic | | | 43,362 | | | | 27,304 | | | | 43,083 | | | | 27,052 | |
Diluted | | | 45,731 | | | | 32,859 | | | | 45,656 | | | | 32,987 | |
ADJUSTED EARNINGS PER SHARE* | | $ | 0.19 | | | $ | 0.17 | | | $ | 0.47 | | | $ | 0.43 | |
ADJUSTED SHARES OUTSTANDING* | | | 45,731 | | | | 39,257 | | | | 45,656 | | | | 38,697 | |
*Please refer to the exhibit to this press release for a reconciliation of adjusted earnings per share to earnings per share, respectively.
IPGP Q3 Results/6
IPG PHOTONICS CORPORATION
CONSOLIDATED BALANCE SHEETS
| | | | | | | | |
| | September 30, | | | December 31, | |
| | 2007 | | | 2006 | |
| | (in thousands, except share data) | |
ASSETS | | | | | | | | |
CURRENT ASSETS: | | | | | | | | |
Cash and cash equivalents | | $ | 44,750 | | | $ | 75,667 | |
Accounts receivable, net | | | 33,277 | | | | 22,353 | |
Inventories, net | | | 58,850 | | | | 42,162 | |
Income taxes receivable | | | 7,663 | | | | 80 | |
Prepaid expenses and other current assets | | | 9,449 | | | | 6,586 | |
Deferred income taxes | | | 7,334 | | | | 9,591 | |
| | | | | | |
Total current assets | | | 161,323 | | | | 156,439 | |
DEFERRED INCOME TAXES | | | 167 | | | | 3,801 | |
PROPERTY, PLANT, AND EQUIPMENT, Net | | | 89,811 | | | | 67,153 | |
OTHER ASSETS | | | 6,911 | | | | 5,099 | |
| | | | | | |
TOTAL | | $ | 258,212 | | | $ | 232,492 | |
| | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | |
CURRENT LIABILITIES: | | | | | | | | |
Revolving line-of-credit facilities | | $ | 15,566 | | | $ | 2,603 | |
Current portion of long-term debt | | | — | | | | 8,299 | |
Accounts payable | | | 9,204 | | | | 7,640 | |
Accrued expenses and other liabilities | | | 17,909 | | | | 13,940 | |
Income taxes payable | | | 199 | | | | 8,289 | |
| | | | | | |
Total current liabilities | | | 42,878 | | | | 40,771 | |
| | | | | | |
DEFERRED INCOME TAXES | | | 3,731 | | | | 232 | |
| | | | | | |
LONG-TERM DEBT | | | 20,000 | | | | 30,068 | |
| | | | | | |
COMMITMENTS AND CONTINGENCIES | | | | | | | | |
MINORITY INTERESTS | | | 4,067 | | | | 2,827 | |
| | | | | | |
STOCKHOLDERS’ EQUITY: | | | | | | | | |
Common stock | | | 4 | | | | 4 | |
Additional paid-in capital | | | 273,720 | | | | 271,122 | |
Notes receivable from stockholders | | | — | | | | (23 | ) |
Accumulated deficit | | | (98,834 | ) | | | (120,392 | ) |
Accumulated other comprehensive income | | | 12,646 | | | | 7,883 | |
| | | | | | |
Total stockholders’ equity | | | 187,536 | | | | 158,594 | |
| | | | | | |
TOTAL | | $ | 258,212 | | | $ | 232,492 | |
| | | | | | |
IPGP Q3 Results/7
GAAP TO NON-GAAP RECONCILIATION—NET INCOME AND EARNINGS PER SHARE
| | | | | | | | | | | | | | | | |
| | September 30, | | | September 30, | |
RECONCILIATION OF BASIC EPS TO ADJUSTED EPS — FOR THREE MONTHS ENDED | | 2007 | | | EPS | | | 2006 | | | EPS | |
| | (in thousands, except for per share data) | |
Reconciliation of shares used to calculate adjusted EPS | | | | | | | | | | | | | | | | |
Weighted average basic shares outstanding | | | 43,362 | | | | | | | | 27,304 | | | | | |
Total common shares issued upon conversion of preferred stock | | | — | | | | | | | | 9,296 | | | | | |
Potentially dilutive options | | | 2,369 | | | | | | | | 2,657 | | | | | |
| | | | | | | | | | | | | |
Adjusted common equivalent shares outstanding | | | 45,731 | | | | | | | | 39,257 | | | | | |
| | | | | | | | | | | | | |
Net income allocable to common stockholders used to calculate basic EPS | | $ | 8,557 | | | $ | 0.20 | | | $ | 3,624 | | | $ | 0.13 | |
Anti-dilutive and dilutive effect of additional shares on basic EPS | | | | | | | (0.01 | ) | | | | | | | (0.04 | ) |
Accretion of preferred stock | | | — | | | | — | | | | 518 | | | | 0.01 | |
Income attributable to preferred stock | | | — | | | | — | | | | 605 | | | | 0.02 | |
| | | | | | | | | | | | |
Net income | | $ | 8,557 | | | $ | 0.19 | | | $ | 4,747 | | | $ | 0.12 | |
Fair value adjustment to series B warrants | | | — | | | | — | | | | 2,137 | | | | 0.05 | |
| | | | | | | | | | | | |
Adjusted net income | | $ | 8,557 | | | $ | 0.19 | | | $ | 6,884 | | | $ | 0.17 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | September 30, | | | September 30, | |
RECONCILIATION OF BASIC EPS TO ADJUSTED EPS — FOR NINE MONTHS ENDED | | 2007 | | | EPS | | | 2006 | | | EPS | |
| | (in thousands, except for per share data) | |
Reconciliation of shares used to calculate adjusted EPS | | | | | | | | | | | | | | | | |
Weighted average basic shares outstanding | | | 43,083 | | | | | | | | 27,052 | | | | | |
Total common shares issued upon conversion of preferred stock | | | — | | | | | | | | 9,296 | | | | | |
Potentially dilutive options | | | 2,573 | | | | | | | | 2,349 | | | | | |
| | | | | | | | | | | | | | |
Adjusted common equivalent shares outstanding | | | 45,656 | | | | | | | | 38,697 | | | | | |
| | �� | | | | | | | | | | | | |
Net income allocable to common stockholders used to calculate basic EPS | | $ | 21,558 | | | $ | 0.50 | | | $ | 9,435 | | | $ | 0.34 | |
Anti-dilutive and dilutive effect of additional shares on basic EPS | | | | | | $ | (0.03 | ) | | | | | | $ | (0.11 | ) |
Accretion of preferred stock | | | — | | | | — | | | | 1,554 | | | $ | 0.04 | |
Income attributable to preferred stock | | | — | | | | — | | | | 1,608 | | | $ | 0.04 | |
| | | | | | | | | | | | |
Net income | | $ | 21,558 | | | $ | 0.47 | | | $ | 12,597 | | | $ | 0.31 | |
Fair value adjustment to series B warrants | | | — | | | | — | | | | 4,356 | | | $ | 0.12 | |
| | | | | | | | | | | | |
Adjusted net income | | $ | 21,558 | | | $ | 0.47 | | | $ | 16,953 | | | $ | 0.43 | |
| | | | | | | | | | | | |